AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2017
Jun 8, 2017
34975_dirs_2017-06-08_f132701d-f307-49e9-87d4-1bb32b49ff86.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2017-05-18
Reporting Person: LEWIS EARL R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-05-18 | Common Stock | D | 9200 | $0.00 | Disposed | 467350 | Direct |
Footnotes
F1: The subject restricted stock units were granted to the reporting person on January 3, 2017 and were forfeited as a result of the reporting person stepping down from his roles as Chairman of the Board of Directors, Chairman and Member of the Governance Committee, and Member of the Compensation Committee of the Issuer.
F2: Includes (a) a deferred stock award of 31,300 restricted stock units which fully vest on the earlier of (i) the date of the Issuer's next Annual Meeting of Stockholders after May 18, 2017, immediately prior to the commencement of such meeting, and (ii) May 18, 2018; (b) a deferred stock award of 9,450 restricted stock units which vest quarterly in equal installments on June 30, 2017, September 30, 2017 and December 31, 2017; and (c) 426,600 shares of common stock held by the Reporting Person.